Death receptor Fas (CD95) signaling in the central nervous system: tuning neuroplasticity?

被引:31
|
作者
Reich, Arno
Spering, Christopher
Schulz, Joerg B. [1 ]
机构
[1] Univ Gottingen, Dept Neurodegenerat & Restorat Res, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany
关键词
D O I
10.1016/j.tins.2008.06.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
For over a decade, neuroscientific research has focused on processes of apoptosis and its contribution to the pathophysiology of neurological diseases. In the central nervous system, the degree of intrinsic mitochondrial-mediated apoptotic signaling expresses a cell's individual metabolic stress, whereas activation of the extrinsic death receptor-induced cascade is regarded as a sign of imbalanced cellular networks. Under physiological conditions, most neurons possess death receptors without being sensitive to receptor-mediated apoptosis. This paradox raises two questions: what is the evolutionary advantage of expressing potentially harmful proteins? How is their signaling controlled? This review summarizes the functional relevance of FasL-Fas signaling - a quintessential death ligand/receptor system - in different neurological disease models ranging from traumatic, inflammatory and ischemic to neurodegenerative processes. Furthermore, it outlines alternative non-apoptotic Fas signaling, shedding new light on its neuroplastic capacity. Finally, receptor-proximal regulatory proteins are introduced and identified as potential protagonists of disease-modifying neurological therapies.
引用
收藏
页码:478 / 486
页数:9
相关论文
共 50 条
  • [1] Regulation of CD95/Fas signaling at the DISC
    I N Lavrik
    P H Krammer
    Cell Death & Differentiation, 2012, 19 : 36 - 41
  • [2] Regulation of CD95/Fas signaling at the DISC
    Lavrik, I. N.
    Krammer, P. H.
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (01): : 36 - 41
  • [3] The CD95(APO-1/Fas) receptor/ligand system: Death signals and diseases
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 159 - 160
  • [4] Hyperosmotic activation of the CD95 death receptor system
    Reinehr, R.
    Hauessinger, D.
    ACTA PHYSIOLOGICA, 2006, 187 (1-2) : 199 - 203
  • [5] Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer
    Watson, C. J.
    O'Kane, H.
    Maxwell, P.
    Sharaf, O.
    Petak, I.
    Hyland, P. L.
    O'Rouke, D.
    McKnight, J.
    Canning, P.
    Williamson, K.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (03) : 645 - 654
  • [6] Control of neuronal branching by the death receptor CD95 (Fas/Apo-1)
    C Zuliani
    S Kleber
    S Klussmann
    T Wenger
    M Kenzelmann
    N Schreglmann
    A Martinez
    J A del Rio
    E Soriano
    P Vodrazka
    R Kuner
    H-J Groene
    I Herr
    P H Krammer
    A Martin-Villalba
    Cell Death & Differentiation, 2006, 13 : 31 - 40
  • [7] Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor
    Fu, Qingshan
    Fu, Tian-Min
    Cruz, Anthony C.
    Sengupta, Prabuddha
    Thomas, Stacy K.
    Wang, Shuqing
    Siegel, Richard M.
    Wu, Hao
    Chou, James J.
    MOLECULAR CELL, 2016, 61 (04) : 602 - 613
  • [8] Control of neuronal branching by the death receptor CD95 (Fas/Apo-1)
    Zuliani, C
    Kleber, S
    Klussmann, S
    Wenger, T
    Kenzelmann, M
    Schreglmann, N
    Martinez, A
    del Rio, JA
    Soriano, E
    Vodrazka, P
    Kuner, R
    Groene, HJ
    Herr, I
    Krammer, PH
    Martin-Villalba, A
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (01): : 31 - 40
  • [9] Synergy between T cell receptor and Fas (CD95/APO-1) signaling in mouse thymocyte death
    Fisher, GH
    Lenardo, MJ
    ZunigaPflucker, JC
    CELLULAR IMMUNOLOGY, 1996, 169 (01) : 99 - 106
  • [10] Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy
    Gajate, Consuelo
    Mollinedo, Faustino
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (03) : 274 - 283